Skip to content

A Prospective, Randomised, Double Blind, Placebo Controlled Group Study Of The Benefits Of Omega 3 Fish Oils (Concentrated Fish Oils 500 milligrams) In Children Between the Ages Of 11-16 Years

A Prospective, Randomised, Double Blind, Placebo Controlled Group Study Of The Benefits Of Omega 3 Fish Oils (Concentrated Fish Oils 500 milligrams) In Children Between the Ages Of 11-16 Years

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN54901093
Enrollment
100
Registered
2007-09-28
Start date
2006-09-11
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine: Supplements Nutritional, Metabolic, Endocrine Supplements

Interventions

The potential participants of this study are already under the care of the investigators, whether this is from a Health or Educational perspective. This aspect is of great importance as there is no i

Sponsors

Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The sample will be one of convenience. There are approximately 100 children attending the school who may be eligible. Children will be regarded as eligible to participate in the study if all of the following criteria are met: Assuming that participants will not be Gillick competent: 1. Their parent/s and or guardian agree to their child's participation and will provide a written informed consent 2. Must be attending Cambridge Park Special School in Grimsby 3. Their parent/s and or guardian agree to their child receiving the dietary supplement at school and during school term times 4. If and wherever possible, the child's agreement to participate will be obtained 5. The child is physically able to swallow intact encapsulated fish oil. 6. The child has no known allergies to fish oils 7. The child has no known allergies to the placebo

Exclusion criteria

Exclusion criteria: Children will be not be regarded as eligible to participate in the study if any of the following criteria are apply: Assuming that participants will not be Gillick competent 1. Their parent/s and or guardian do not agree to their child's participation and will not provide a written informed consent 2. Children whose parents request them to be given Omega 3 only 3. Not attending Cambridge Park Special School in Grimsby 4. Their parent/s and or guardian do not agree to their child receiving the dietary supplement at school and during school term times 5. The child is not physically able to swallow intact encapsulated fish oil. 6. The child has known allergies to fish oils 7. The child has known allergies to the placebo 8. The child is known to be un-cooperative 9. Children known to be already taking fish oil food supplement

Design outcomes

Primary

MeasureTime frame
Analysis by significance testing (t-Test) Chi-square test and Mantel-Haenszel Test for a matched pairing, log transformation and McNemar Test. The difference between the response of the 2 units in each matched pair besides the difference of each unit's own individual response are analysed.

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026